(State or other jurisdiction | (Commission File Number) | (IRS Employer | ||||||||||||
of incorporation) | Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Emerging growth company | ||||||||||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
IDEX CORPORATION | ||||||||
By: | /s/ WILLIAM K. GROGAN | |||||||
William K. Grogan | ||||||||
Senior Vice President and Chief Financial Officer | ||||||||
July 27, 2023 |
Three Months Ended June 30, | |||||||||||||||||
(Dollars in millions, except per share amounts) | 2023 | 2022 | Increase (Decrease) | ||||||||||||||
Net sales | $ | 846.2 | $ | 796.1 | $ | 50.1 | |||||||||||
Organic net sales growth* | 3 | % | |||||||||||||||
Gross profit | 378.0 | 356.9 | 21.1 | ||||||||||||||
Adjusted gross profit* | 378.0 | 357.3 | 20.7 | ||||||||||||||
Net income attributable to IDEX | 138.6 | 138.2 | 0.4 | ||||||||||||||
Adjusted net income attributable to IDEX* | 165.4 | 153.6 | 11.8 | ||||||||||||||
Adjusted EBITDA* | 240.7 | 219.2 | 21.5 | ||||||||||||||
Diluted EPS attributable to IDEX | 1.82 | 1.81 | 0.01 | ||||||||||||||
Adjusted diluted EPS attributable to IDEX* | 2.18 | 2.02 | 0.16 | ||||||||||||||
Cash flows from operating activities | 141.2 | 112.3 | 28.9 | ||||||||||||||
Free cash flow* | 119.6 | 96.7 | 22.9 | ||||||||||||||
Gross margin | 44.7 | % | 44.8 | % | (10) bps | ||||||||||||
Adjusted gross margin* | 44.7 | % | 44.9 | % | (20) bps | ||||||||||||
Net income margin | 16.4 | % | 17.3 | % | (90) bps | ||||||||||||
Adjusted EBITDA margin* | 28.4 | % | 27.5 | % | 90 bps | ||||||||||||
*These are non-GAAP measures. See the definitions of these non-GAAP measures in the section in this release titled “Non-GAAP Measures of Financial Performance” and reconciliations to their most directly comparable GAAP financial measures in the reconciliation tables at the end of this release. |
Three Months Ended June 30, | |||||||||||||||||
(Dollars in millions) | 2023 | 2022 | Increase (Decrease) | ||||||||||||||
Net sales | $ | 325.1 | $ | 299.9 | $ | 25.2 | |||||||||||
Adjusted EBITDA | 114.1 | 95.0 | 19.1 | ||||||||||||||
Adjusted EBITDA margin | 35.1 | % | 31.7 | % | 340 bps |
Three Months Ended June 30, | |||||||||||||||||
(Dollars in millions) | 2023 | 2022 | Increase (Decrease) | ||||||||||||||
Net sales | $ | 339.5 | $ | 326.0 | $ | 13.5 | |||||||||||
Adjusted EBITDA | 93.7 | 103.6 | (9.9) | ||||||||||||||
Adjusted EBITDA margin | 27.6 | % | 31.8 | % | (420) bps |
Three Months Ended June 30, | |||||||||||||||||
(Dollars in millions) | 2023 | 2022 | Increase (Decrease) | ||||||||||||||
Net sales | $ | 184.8 | $ | 171.2 | $ | 13.6 | |||||||||||
Adjusted EBITDA | 54.5 | 45.1 | 9.4 | ||||||||||||||
Adjusted EBITDA margin | 29.4 | % | 26.4 | % | 300 bps |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Net sales | $ | 846.2 | $ | 796.1 | $ | 1,691.6 | $ | 1,547.2 | |||||||||||||||
Cost of sales | 468.2 | 439.2 | 931.1 | 847.8 | |||||||||||||||||||
Gross profit | 378.0 | 356.9 | 760.5 | 699.4 | |||||||||||||||||||
Selling, general and administrative expenses | 174.3 | 167.5 | 364.0 | 321.8 | |||||||||||||||||||
Restructuring expenses and asset impairments | 3.6 | 2.8 | 4.1 | 3.4 | |||||||||||||||||||
Operating income | 200.1 | 186.6 | 392.4 | 374.2 | |||||||||||||||||||
Other expense (income) - net | 8.3 | — | 7.7 | (2.3) | |||||||||||||||||||
Interest expense | 13.3 | 9.5 | 26.4 | 19.0 | |||||||||||||||||||
Income before income taxes | 178.5 | 177.1 | 358.3 | 357.5 | |||||||||||||||||||
Provision for income taxes | 40.0 | 39.0 | 80.0 | 79.5 | |||||||||||||||||||
Net income | 138.5 | 138.1 | 278.3 | 278.0 | |||||||||||||||||||
Net loss attributable to noncontrolling interest | 0.1 | 0.1 | 0.1 | 0.2 | |||||||||||||||||||
Net income attributable to IDEX | $ | 138.6 | $ | 138.2 | $ | 278.4 | $ | 278.2 | |||||||||||||||
Earnings per Common Share: | |||||||||||||||||||||||
Basic earnings per common share attributable to IDEX | $ | 1.83 | $ | 1.82 | $ | 3.68 | $ | 3.66 | |||||||||||||||
Diluted earnings per common share attributable to IDEX | $ | 1.82 | $ | 1.81 | $ | 3.66 | $ | 3.65 | |||||||||||||||
Share Data: | |||||||||||||||||||||||
Basic weighted average common shares outstanding | 75.6 | 75.8 | 75.6 | 76.0 | |||||||||||||||||||
Diluted weighted average common shares outstanding | 75.9 | 76.1 | 75.9 | 76.2 |
June 30, 2023 | December 31, 2022 | ||||||||||
Assets | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 457.0 | $ | 430.2 | |||||||
Receivables - net | 455.2 | 442.8 | |||||||||
Inventories | 482.5 | 470.9 | |||||||||
Other current assets | 93.2 | 55.4 | |||||||||
Total current assets | 1,487.9 | 1,399.3 | |||||||||
Property, plant and equipment - net | 421.6 | 382.1 | |||||||||
Goodwill and intangible assets | 3,671.7 | 3,585.9 | |||||||||
Other noncurrent assets | 138.7 | 144.6 | |||||||||
Total assets | $ | 5,719.9 | $ | 5,511.9 | |||||||
Liabilities and equity | |||||||||||
Current liabilities | |||||||||||
Trade accounts payable | $ | 189.7 | $ | 208.9 | |||||||
Accrued expenses | 247.9 | 289.1 | |||||||||
Short-term borrowings | 0.5 | — | |||||||||
Dividends payable | 48.5 | 45.6 | |||||||||
Total current liabilities | 486.6 | 543.6 | |||||||||
Long-term borrowings | 1,471.5 | 1,468.7 | |||||||||
Other noncurrent liabilities | 482.9 | 460.0 | |||||||||
Total liabilities | 2,441.0 | 2,472.3 | |||||||||
Shareholders' equity | 3,278.7 | 3,039.3 | |||||||||
Noncontrolling interest | 0.2 | 0.3 | |||||||||
Total equity | 3,278.9 | 3,039.6 | |||||||||
Total liabilities and equity | $ | 5,719.9 | $ | 5,511.9 |
Six Months Ended June 30, | |||||||||||
2023 | 2022 | ||||||||||
Cash flows from operating activities | |||||||||||
Net income | $ | 278.3 | $ | 278.0 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Gains on sales of assets | (0.2) | (2.6) | |||||||||
Asset impairments | 0.5 | 0.2 | |||||||||
Credit loss on note receivable from collaborative partner | 7.7 | — | |||||||||
Depreciation | 27.2 | 24.7 | |||||||||
Amortization of intangible assets | 46.8 | 32.2 | |||||||||
Amortization of debt issuance expenses | 0.8 | 0.8 | |||||||||
Share-based compensation expense | 17.0 | 13.5 | |||||||||
Deferred income taxes | — | (0.2) | |||||||||
Changes in (net of the effect from acquisitions and foreign exchange): | |||||||||||
Receivables | (5.8) | (68.7) | |||||||||
Inventories | (2.0) | (84.5) | |||||||||
Other current assets | (18.6) | (17.8) | |||||||||
Trade accounts payable | (17.9) | 36.2 | |||||||||
Deferred revenue | 4.2 | 1.3 | |||||||||
Accrued expenses | (52.5) | (22.5) | |||||||||
Other - net | 3.6 | 1.4 | |||||||||
Net cash flows provided by operating activities | 289.1 | 192.0 | |||||||||
Cash flows from investing activities | |||||||||||
Purchases of property, plant and equipment | (48.2) | (31.7) | |||||||||
Acquisition of businesses, net of cash acquired | (110.3) | (234.9) | |||||||||
Proceeds from disposal of fixed assets | 1.3 | 6.6 | |||||||||
Purchases of marketable securities | (19.1) | — | |||||||||
Other - net | (0.3) | (0.1) | |||||||||
Net cash flows used in investing activities | (176.6) | (260.1) | |||||||||
Cash flows from financing activities | |||||||||||
Proceeds from issuance of 5.13% Senior Notes | 100.0 | — | |||||||||
Payment of 3.20% Senior Notes | (100.0) | — | |||||||||
Dividends paid | (93.9) | (86.9) | |||||||||
Proceeds from stock option exercises | 8.0 | 5.2 | |||||||||
Repurchases of common stock | (1.0) | (110.4) | |||||||||
Shares surrendered for tax withholding | (4.6) | (4.9) | |||||||||
Other - net | (0.5) | (0.1) | |||||||||
Net cash flows used in financing activities | (92.0) | (197.1) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | 6.3 | (32.4) | |||||||||
Net increase (decrease) in cash and cash equivalents | 26.8 | (297.6) | |||||||||
Cash and cash equivalents at beginning of year | 430.2 | 855.4 | |||||||||
Cash and cash equivalents at end of period | $ | 457.0 | $ | 557.8 |
Three Months Ended June 30, (a) | Six Months Ended June 30, (a) | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Fluid & Metering Technologies | ||||||||||||||||||||||||||
Net sales | $ | 325.1 | $ | 299.9 | $ | 646.9 | $ | 571.9 | ||||||||||||||||||
Adjusted EBITDA(b) | 114.1 | 95.0 | 220.3 | 183.4 | ||||||||||||||||||||||
Adjusted EBITDA margin | 35.1 | % | 31.7 | % | 34.1 | % | 32.1 | % | ||||||||||||||||||
Depreciation | 4.1 | 4.2 | 7.2 | 8.1 | ||||||||||||||||||||||
Amortization of intangible assets | 5.7 | 5.6 | 11.7 | 9.3 | ||||||||||||||||||||||
Capital expenditures | 5.6 | 4.8 | 13.0 | 9.7 | ||||||||||||||||||||||
Health & Science Technologies | ||||||||||||||||||||||||||
Net sales | $ | 339.5 | $ | 326.0 | $ | 690.5 | $ | 641.2 | ||||||||||||||||||
Adjusted EBITDA(b) | 93.7 | 103.6 | 194.4 | 203.4 | ||||||||||||||||||||||
Adjusted EBITDA margin | 27.6 | % | 31.8 | % | 28.2 | % | 31.7 | % | ||||||||||||||||||
Depreciation | 7.8 | 6.1 | 15.1 | 12.2 | ||||||||||||||||||||||
Amortization of intangible assets | 15.9 | 9.7 | 31.8 | 19.6 | ||||||||||||||||||||||
Capital expenditures | 12.6 | 7.3 | 28.7 | 16.5 | ||||||||||||||||||||||
Fire & Safety/Diversified Products | ||||||||||||||||||||||||||
Net sales | $ | 184.8 | $ | 171.2 | $ | 359.2 | $ | 335.9 | ||||||||||||||||||
Adjusted EBITDA(b) | 54.5 | 45.1 | 104.2 | 89.5 | ||||||||||||||||||||||
Adjusted EBITDA margin | 29.4 | % | 26.4 | % | 29.0 | % | 26.6 | % | ||||||||||||||||||
Depreciation | 2.3 | 2.1 | 4.4 | 4.2 | ||||||||||||||||||||||
Amortization of intangible assets | 1.6 | 1.6 | 3.3 | 3.3 | ||||||||||||||||||||||
Capital expenditures | 3.0 | 3.3 | 5.9 | 5.3 | ||||||||||||||||||||||
Corporate Office and Eliminations | ||||||||||||||||||||||||||
Intersegment sales eliminations | $ | (3.2) | $ | (1.0) | $ | (5.0) | $ | (1.8) | ||||||||||||||||||
Adjusted EBITDA(b) | (21.6) | (24.5) | (48.4) | (42.4) | ||||||||||||||||||||||
Depreciation | 0.2 | 0.1 | 0.5 | 0.2 | ||||||||||||||||||||||
Capital expenditures | 0.4 | 0.2 | 0.6 | 0.2 | ||||||||||||||||||||||
Company | ||||||||||||||||||||||||||
Net sales | $ | 846.2 | $ | 796.1 | $ | 1,691.6 | $ | 1,547.2 | ||||||||||||||||||
Adjusted EBITDA(c) | 240.7 | 219.2 | 470.5 | 433.9 | ||||||||||||||||||||||
Adjusted EBITDA margin(c) | 28.4 | % | 27.5 | % | 27.8 | % | 28.0 | % | ||||||||||||||||||
Depreciation | 14.4 | 12.5 | 27.2 | 24.7 | ||||||||||||||||||||||
Amortization of intangible assets | 23.2 | 16.9 | 46.8 | 32.2 | ||||||||||||||||||||||
Capital expenditures | 21.6 | 15.6 | 48.2 | 31.7 | ||||||||||||||||||||||
(a) | Three and six month data includes the results of the KZValve acquisition (May 2022) and the Nexsight acquisition (February 2022) in the FMT segment as well as the Iridian acquisition (May 2023) and Muon Group acquisition (November 2022) in the HST segment from the date of acquisition. Three and six month data also includes the results of Knight LLC ("Knight") (September 2022) in the FMT segment through the date of disposition. | |||||||||||||||||||||||||
(b) | Segment Adjusted EBITDA excludes unallocated corporate costs which are included in Corporate Office and Eliminations. | |||||||||||||||||||||||||
(c) | These are non-GAAP financial measures. For a reconciliation of these non-GAAP financial measures to their most directly comparable measure calculated and presented in accordance with GAAP, see the reconciliation tables below. |
Three Months Ended June 30, 2023 | Six Months Ended June 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | IDEX | FMT | HST | FSDP | IDEX | ||||||||||||||||||||||||||||||||||||||||
Change in net sales | 8 | % | 4 | % | 8 | % | 6 | % | 13 | % | 8 | % | 7 | % | 9 | % | |||||||||||||||||||||||||||||||
- Net impact from acquisitions/divestitures | (1 | %) | 10 | % | — | 4 | % | 4 | % | 11 | % | — | 6 | % | |||||||||||||||||||||||||||||||||
- Impact from foreign currency | (1 | %) | — | — | (1 | %) | (1 | %) | (1 | %) | (2 | %) | (1 | %) | |||||||||||||||||||||||||||||||||
Change in organic net sales | 10 | % | (6 | %) | 8 | % | 3 | % | 10 | % | (2 | %) | 9 | % | 4 | % |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(Dollars in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Gross profit | $ | 378.0 | $ | 356.9 | $ | 760.5 | $ | 699.4 | |||||||||||||||
+ Fair value inventory step-up charges | — | 0.4 | — | 0.4 | |||||||||||||||||||
Adjusted gross profit | $ | 378.0 | $ | 357.3 | $ | 760.5 | $ | 699.8 | |||||||||||||||
Net sales | $ | 846.2 | $ | 796.1 | $ | 1,691.6 | $ | 1,547.2 | |||||||||||||||
Gross margin | 44.7 | % | 44.8 | % | 45.0 | % | 45.2 | % | |||||||||||||||
Adjusted gross margin | 44.7 | % | 44.9 | % | 45.0 | % | 45.2 | % |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
(In millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Reported net income attributable to IDEX | $ | 138.6 | $ | 138.2 | $ | 278.4 | $ | 278.2 | ||||||||||||||||||
+ Restructuring expenses and asset impairments | 3.6 | 2.8 | 4.1 | 2.8 | ||||||||||||||||||||||
+ Tax impact on restructuring expenses and asset impairments | (0.8) | (0.7) | (0.9) | (0.7) | ||||||||||||||||||||||
+ Fair value inventory step-up charges | — | 0.4 | — | 0.4 | ||||||||||||||||||||||
+ Tax impact on fair value inventory step-up charges | — | (0.1) | — | (0.1) | ||||||||||||||||||||||
- Gains on sales of assets | — | — | — | (2.7) | ||||||||||||||||||||||
+ Tax impact on gains on sales of assets | — | — | — | 0.6 | ||||||||||||||||||||||
+ Credit loss on note receivable from collaborative partner(1) | 7.7 | — | 7.7 | — | ||||||||||||||||||||||
+ Tax impact on credit loss on note receivable from collaborative partner | (1.6) | — | (1.6) | — | ||||||||||||||||||||||
+ Acquisition-related intangible asset amortization | 23.2 | 16.9 | 46.8 | 32.2 | ||||||||||||||||||||||
+ Tax impact on acquisition-related intangible asset amortization | (5.3) | (3.9) | (10.5) | (7.3) | ||||||||||||||||||||||
Adjusted net income attributable to IDEX | $ | 165.4 | $ | 153.6 | $ | 324.0 | $ | 303.4 |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
(In millions, except per share amounts) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Reported diluted EPS attributable to IDEX | $ | 1.82 | $ | 1.81 | $ | 3.66 | $ | 3.65 | ||||||||||||||||||
+ Restructuring expenses and asset impairments | 0.05 | 0.04 | 0.06 | 0.04 | ||||||||||||||||||||||
+ Tax impact on restructuring expenses and asset impairments | (0.01) | (0.01) | (0.01) | (0.01) | ||||||||||||||||||||||
+ Fair value inventory step-up charges | — | — | — | — | ||||||||||||||||||||||
+ Tax impact on fair value inventory step-up charges | — | — | — | — | ||||||||||||||||||||||
- Gains on sales of assets | — | — | — | (0.03) | ||||||||||||||||||||||
+ Tax impact on gains on sales of assets | — | — | — | 0.01 | ||||||||||||||||||||||
+ Credit loss on note receivable from collaborative partner(1) | 0.10 | — | 0.10 | — | ||||||||||||||||||||||
+ Tax impact on credit loss on note receivable from collaborative partner | (0.02) | — | (0.02) | — | ||||||||||||||||||||||
+ Acquisition-related intangible asset amortization | 0.31 | 0.22 | 0.62 | 0.42 | ||||||||||||||||||||||
+ Tax impact on acquisition-related intangible asset amortization | (0.07) | (0.04) | (0.14) | (0.10) | ||||||||||||||||||||||
Adjusted diluted EPS attributable to IDEX | $ | 2.18 | $ | 2.02 | $ | 4.27 | $ | 3.98 | ||||||||||||||||||
Diluted weighted average shares outstanding | 75.9 | 76.1 | 75.9 | 76.2 |
Three Months Ended June 30, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | |||||||||||||||||||||||||||||||||||||||||||||||||
Reported net income | $ | — | $ | — | $ | — | $ | — | $ | 138.5 | $ | — | $ | — | $ | — | $ | — | $ | 138.1 | |||||||||||||||||||||||||||||||||||||||
+ Provision for income taxes | — | — | — | — | 40.0 | — | — | — | — | 39.0 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Interest expense | — | — | — | — | 13.3 | — | — | — | — | 9.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
- Other income (expense) - net | — | — | — | — | (8.3) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Operating income (loss) | 103.3 | 67.5 | 50.6 | (21.3) | 200.1 | 82.9 | 86.5 | 39.9 | (22.7) | 186.6 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Other income (expense) - net | 0.4 | (0.2) | (0.3) | (8.2) | (8.3) | 0.2 | 1.2 | 0.5 | (1.9) | — | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Depreciation | 4.1 | 7.8 | 2.3 | 0.2 | 14.4 | 4.2 | 6.1 | 2.1 | 0.1 | 12.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Amortization | 5.7 | 15.9 | 1.6 | — | 23.2 | 5.6 | 9.7 | 1.6 | — | 16.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Fair value inventory step-up charges | — | — | — | — | — | 0.4 | — | — | — | 0.4 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Restructuring expenses and asset impairments | 0.6 | 2.7 | 0.3 | — | 3.6 | 1.7 | 0.1 | 1.0 | — | 2.8 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Credit loss on note receivable from collaborative partner(1) | — | — | — | 7.7 | 7.7 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 114.1 | $ | 93.7 | $ | 54.5 | $ | (21.6) | $ | 240.7 | $ | 95.0 | $ | 103.6 | $ | 45.1 | $ | (24.5) | $ | 219.2 | |||||||||||||||||||||||||||||||||||||||
Net sales (eliminations) | $ | 325.1 | $ | 339.5 | $ | 184.8 | $ | (3.2) | $ | 846.2 | $ | 299.9 | $ | 326.0 | $ | 171.2 | $ | (1.0) | $ | 796.1 | |||||||||||||||||||||||||||||||||||||||
Net income margin | 16.4 | % | 17.3 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA margin | 35.1 | % | 27.6 | % | 29.4 | % | n/m | 28.4 | % | 31.7 | % | 31.8 | % | 26.4 | % | n/m | 27.5 | % |
Six Months Ended June 30, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | |||||||||||||||||||||||||||||||||||||||||||||||||
Reported net income | $ | — | $ | — | $ | — | $ | — | $ | 278.3 | $ | — | $ | — | $ | — | $ | — | $ | 278.0 | |||||||||||||||||||||||||||||||||||||||
+ Provision for income taxes | — | — | — | — | 80.0 | — | — | — | — | 79.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Interest expense | — | — | — | — | 26.4 | — | — | — | — | 19.0 | |||||||||||||||||||||||||||||||||||||||||||||||||
- Other income (expense) - net | — | — | — | — | (7.7) | — | — | — | — | 2.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
Operating income (loss) | 199.8 | 145.0 | 96.6 | (49.0) | 392.4 | 163.3 | 170.1 | 80.4 | (39.6) | 374.2 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Other income (expense) - net | 0.9 | (0.5) | (0.5) | (7.6) | (7.7) | 1.8 | 1.4 | 2.1 | (3.0) | 2.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Depreciation | 7.2 | 15.1 | 4.4 | 0.5 | 27.2 | 8.1 | 12.2 | 4.2 | 0.2 | 24.7 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Amortization | 11.7 | 31.8 | 3.3 | — | 46.8 | 9.3 | 19.6 | 3.3 | — | 32.2 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Fair value inventory step-up charges | — | — | — | — | — | 0.4 | — | — | — | 0.4 | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Restructuring expenses and asset impairments | 0.7 | 3.0 | 0.4 | — | 4.1 | 1.7 | 0.1 | 1.0 | — | 2.8 | |||||||||||||||||||||||||||||||||||||||||||||||||
- Gains on sales of assets | — | — | — | — | — | (1.2) | — | (1.5) | — | (2.7) | |||||||||||||||||||||||||||||||||||||||||||||||||
+ Credit loss on note receivable from collaborative partner(1) | — | — | — | 7.7 | 7.7 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 220.3 | $ | 194.4 | $ | 104.2 | $ | (48.4) | $ | 470.5 | $ | 183.4 | $ | 203.4 | $ | 89.5 | $ | (42.4) | $ | 433.9 | |||||||||||||||||||||||||||||||||||||||
Net sales (eliminations) | $ | 646.9 | $ | 690.5 | $ | 359.2 | $ | (5.0) | $ | 1,691.6 | $ | 571.9 | $ | 641.2 | $ | 335.9 | $ | (1.8) | $ | 1,547.2 | |||||||||||||||||||||||||||||||||||||||
Net income margin | 16.4 | % | 18.0 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA margin | 34.1 | % | 28.2 | % | 29.0 | % | n/m | 27.8 | % | 32.1 | % | 31.7 | % | 26.6 | % | n/m | 28.0 | % |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(Dollars in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Cash flows from operating activities | $ | 141.2 | $ | 112.3 | $ | 289.1 | $ | 192.0 | |||||||||||||||
- Capital expenditures | 21.6 | 15.6 | 48.2 | 31.7 | |||||||||||||||||||
Free cash flow | $ | 119.6 | $ | 96.7 | $ | 240.9 | $ | 160.3 |
Guidance | ||||||||||||||
Third Quarter 2023 | Full Year 2023 | |||||||||||||
Estimated diluted EPS attributable to IDEX | $1.60 - $1.65 | $6.80 - $6.90 | ||||||||||||
+ Restructuring expenses and asset impairments | — | 0.06 | ||||||||||||
+ Tax impact on restructuring expenses and asset impairments | — | (0.01) | ||||||||||||
+ Credit loss on note receivable from collaborative partner(1) | — | 0.10 | ||||||||||||
+ Tax impact on credit loss on note receivable from collaborative partner | — | (0.02) | ||||||||||||
+ Acquisition-related intangible asset amortization | 0.32 | 1.26 | ||||||||||||
+ Tax impact on acquisition-related intangible asset amortization | (0.08) | (0.29) | ||||||||||||
Estimated adjusted diluted EPS attributable to IDEX | $1.84 - $1.89 | $7.90 - $8.00 |
Guidance | |||||||||||||||||||||||
Third Quarter 2023 | Full Year 2023 | ||||||||||||||||||||||
(Dollars in millions) | Low End | High End | Low End | High End | |||||||||||||||||||
Reported net income | $ | 121.3 | $ | 124.5 | $ | 516.6 | $ | 524.1 | |||||||||||||||
+ Provision for income taxes | 35.0 | 36.0 | 148.8 | 151.0 | |||||||||||||||||||
+ Interest expense | 14.0 | 14.0 | 54.4 | 54.4 | |||||||||||||||||||
+ Depreciation | 15.8 | 15.8 | 59.2 | 59.2 | |||||||||||||||||||
+ Amortization of intangible assets | 24.1 | 24.1 | 94.9 | 94.9 | |||||||||||||||||||
+ Restructuring expenses and asset impairments | — | — | 4.1 | 4.1 | |||||||||||||||||||
+ Credit loss on note receivable from collaborative partner(1) | — | — | 7.7 | 7.7 | |||||||||||||||||||
Adjusted EBITDA | $ | 210.2 | $ | 214.4 | $ | 885.7 | $ | 895.4 | |||||||||||||||
Net sales | $ | 785.7 | $ | 795.2 | $ | 3,264.1 | $ | 3,284.6 | |||||||||||||||
Net income margin | 15% | 16% | 16% | 16% | |||||||||||||||||||
Adjusted EBITDA margin | 27% | 27% | 27% | 27% |
>81&-/+7R8R(QP" 0Q%)@>P_"[P+#X!T2&R51]KF59;R3N\S#)7/]
MR+/EQCI@%OO,Q+7<#T:F(Y+Q[IT6J^'M2M)P"DEE<=2 %98V='R>!L=5<$\
MC-)[#1\C_LNZ1]IUN]U(C*V=H(P?1[B0;3]=D,@^A-+J!]RU0@H * "@#&U[
MP_8>)K-].U6%+FVDZHXZ$=&5AAD)S_ +7JM1GG\G@/XF_#M=^F27,MO$.EC<-/%Q_TZ/AF]O\
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M4%+9!90M],F-EZ _'$WBG2)[34KE[K4K2=F;S7+2M;R*AC
M?).2H?>AQPN%SC<,BTT ^@J8CY<_:6\8V4&E)X;B9);ZXFCFD08)@ACRP9C_
M O(^T*O4Q[R< KNG]!GJ7P:\.3>%_"EE:72F.XD5[B5#D%3.YD52#]UEC**
MZ]G# \TUW ]$U'4;?2+:6^O'$-O;HTDLASA$499B "3@=@"3V!-/81@^&O&^
MB^,#*-%NEO/LVSS=B2*$\S=LR711\VQ\ 9/RFD/8ZNF(* "@ H * /(/B=?9
M>WLE/0-,P^OR)_)_SKV<%#XJGR7YO]#AKO:/S_K\3RBO8.(* "@ H * "@ H
M * "@#UOX86/_'Q>D?W85/\ X^X_]%UXV-E\-/YO\E^IW4%O+Y?Y_H>LLP0%
MF. !DGT ZUXYVGRUJEZ=1NYKH_\ +61G'L"3M'X# _"OK:9PC#LDOGU_$\
M:3YFWW90K0D* "@ H * "@ H L9]-O5$EO=1M$
MZD=F&,CT93AE/56 8<@4O(-CXO\ V7I98O$-];*=T#6#,Q&=I>.XA6,C..JR
M2XR,X].009]R4Q!0!6N;R"S7?<2)"OK(ZH.PZL0.I _$>M*Z6^@>@ZWNH;I=
M\#I*O]Y#\U)%%UT GI@% 'S!^U'J_V71;+3%.&O+II6'M*Z6^@>@MO=0W:[[>1)4_O(RL/S4D4)KH&Q
M8I@% !0 4 48]3M)9/)CGA:0=461"PS_ +(.>X[=Z5UW0[%ZF(* "@"*:>.W
M7?*RQH.K,0H'XD@4MMP(+6_MKW/V:6*;'7RW5\8QUVD^H_,>M%T]A[%RF(*
M"@ H * "@ H * "@#S7XEWWDV<5HIP9Y-Q'^S&/_ (IE/X5ZF"C>;G_*OQ?_
M +G)7=HJ/=_D>)U[IYX4 % !0 4 % !0 4 % 'HOPVL?/OWNB/EMHSCV>3Y
M1_XZ'KS,9+E@H+[3_!?\&QU4%[S?9?G_ $SW&O!/1/FWQ;??VAJEQ(#E4?RU
M],1_)Q[$@M^-?3X>')2BNZN_GK^6AY51\TF_E]QS==1B% !0 4 % !0 4 %
M!0 4 % !0 4 % !0!WGP\U'['J7V=CA+I"GMO7YD/Z,H_P!ZO.QD.:GS+>+O
M\GH_T^XZ:,K2MW/:M4U&+2;62[F^[$N<=V/15'NQP!]>>*\.$'4DH1W?]7/0
ME)03D^A\R7U[+J,[W4YS)*Q8^G/0#T & !V KZJ$53BH1V1Y#;DVV5*LD*
M"@ H * "@ H * "@ H VM.\/:AJHW6L#NG]\X5/P=RJG'?!)K"=:G2TG))]M
MW]R-(PE+X5^AOCX>:L1G;$/8R#^@(KF^N4O/[C7V,_+[Q?\ A7>K>D7_ '\'
M^%'URE_>^[_@A[&?E]X?\*[U;TB_[^#_ H^N4O[WW?\$/8S\OO(V^'VKKTC
MC;Z2+_4BFL72[M?(7L9KI^(S_A -8_YY)_W]C_\ BJ?UNEW?W,/8S[?B@_X0
M#6/^>2?]_8__ (JCZW2[O[F'L9]OQ1Z)X&\-SZ<EXH264JJ@,&PB@G.5R/
MF8\C_9%>9B:T:KBH;*_EJ_\ AOQ.JE!PNY;L[^O/.D* /+OB/H?G1+J<0^:+
M"2X[H3\K?\!8X/LP[+7K8.KRMTGL]5Z]?O7Y>9QUX:W 'XUS^PI_R1^XTYY=W]XO_ DVJ_\ /U/_
M -_&_P :/84OY(_<'/+^9_>'_"3:K_S]3_\ ?QO\:/84OY(_<'/+^9_>'_"3
M:K_S]3_]_&_QH]A2_DC]P<\OYG]X?\)-JO\ S]3_ /?QO\:/84OY(_<'/+^9
M_>'_ DVJ_\ /U/_ -_&_P :/84OY(_<'/+^9_>'_"3:K_S]3_\ ?QO\:/84
MOY(_<'/+^9_>:NAZMJNJ7T-I]JGQ(XW?O&^X/F<]>R@UC5ITJ<)3Y(Z+33J]
M%^)<)2E)1N_O/H2OG#U H * "@#S?XB:)]KM1J$0_>VW#XZF(G_V1CGV4L3T
MKT\)5Y)>S>TMO7_@[>MCEK0NN9;K\CQ&O>/."@ H * "@ H * "@ H * "@
MH * "@#U/P9X+^T;=1U!?W?#11,/O^CN/[G=5/WNI^7 ;R,3B;7I4GKU?;R7
MGW?3UV[*5+[4MNB/8J\4[Q: "@ H * "@ H * "@ H * /#/V@YW;PW'I^
MMU:_M+10.Y+F8<=QNB4?4BI>GYC1[9:VZ6<*6\0Q'"BQJ/14 4?H!36F@B>F
M 4 % !0 4 % !0 4 ?"'C'_BM?BK'8CYX8;RUMR.O[NV59+@?]]+-]._2H[^
M?_#%;'W?5DA0!!2 ]=_P"&5+3_ *"LW_@*G_QZF ?\,J6G
M_05F_P# 5/\ X]0 H_94L\\ZK-C_ *]D'_M8_P J-0/K".-85$:#"H H'H ,
M ?E3VT$?$/B/_BJ/B]#:R'=%;7=LBJNO#1YZL5T6OW;?C8QJOE@_/3[_ /@'SK7TQY04 % !0 4
M% !0 4 % '4>#;'[?JL"$96-O-;Z1C
V #Z!XI
M/Q)H7]?U\P/H2F(^*]-_XK#XP2S?>AT^>0GN%%C!Y"D>QN%4_P# JC_/^OP1
M1]J59)2U*^CTRTFO9O\ 5VT4DS_[L:%V_0&D] /D7]F*QDU#4=6UZXYD*I%O
M/\3W$C338/7@Q1D^NX=>:2TT709]CU0CR;XX:O\ V-X.U!U.'N42U4=,^?(J
M2#_OT9#^';J$^W]=QHYO]F_1_P"S?":W1&&U"YGGST.U"+=1],PLP_WL]Z$!
M[7K&HIH]C TV3[
M9%\KM XC#$=2T,J[HF]5WL,YQM'RAZ]!&7JWQH\5?$C=I'@_3Y;59OW;S1DR
MS -US-M2&U4C(+M\PZK(II>OW#/7OA!\'HO $9U'4"MQK$Z[6=L_ NKW9&81"I_BE8+^:C<__ ([7/+%4H[._DE_PR_$T5*;Z6]3N=*^&
MMO!A[^0SG_GFF43Z%OOL/ILK@GC)/2FN7S>K_P E^)TQH)?$[^6W]?@>BVMI
M#8QB&W18HUZ*@ 'UXZD]R>3WKS)2
MJ9J-K5&_AP:Z1=,B/+$XQ6+=NEN\ASA5SR:E.++M.-CC=6
1>1+A)"1[&M3
M0'D:Y!,A//3-0:KITMNY;:2GKZ59\)VYFU8 'CO7)0E[Z.^NKT6NIZ3#N>'D
M]O2O./%%X6O39H3P?FQWKTBY;[-8S/G!5">?I7E.GL;C6FN)L/M)
]>42#)P>M=$=5